Skip to main navigation
Contact Us
About Us
Leadership
Board of Directors
Scientific Advisory Board
Science & Tech
Vorolanib
DURASERT® Technology
VERISOME® Technology
Partnerships and BD Initiatives
Pipeline & Data
Pipeline
EYP-1901
Overview
Clinical Trials
Scientific Publications and Presentations
EYP-2301
Investors
Financial Information
Financials Overview
Stock Information
Analyst Coverage
Annual Reports
Earnings Releases
SEC Filings
Resources
Press Releases
Events & Presentations
IR Contact
E-mail Alerts
Corporate Governance
Governance Overview
Management Team
Board of Directors
Committee Composition
Contact the Board
FAQs
Form 8937
News
Careers
Menu
About Us
Leadership
Board of Directors
Scientific Advisory Board
Science & Tech
Vorolanib
DURASERT® Technology
VERISOME® Technology
Partnerships and BD Initiatives
Pipeline & Data
Pipeline
EYP-1901
Overview
Clinical Trials
Scientific Publications and Presentations
EYP-2301
Investors
Financial Information
Financials Overview
Stock Information
Analyst Coverage
Annual Reports
Earnings Releases
SEC Filings
Resources
Press Releases
Events & Presentations
IR Contact
E-mail Alerts
Corporate Governance
Governance Overview
Management Team
Board of Directors
Committee Composition
Contact the Board
FAQs
Form 8937
News
Careers
Menu
About Us
Leadership
Board of Directors
Scientific Advisory Board
Science & Tech
Vorolanib
DURASERT® Technology
VERISOME® Technology
Partnerships and BD Initiatives
Pipeline & Data
Pipeline
EYP-1901
Overview
Clinical Trials
Scientific Publications and Presentations
EYP-2301
Investors
Financial Information
Financials Overview
Stock Information
Analyst Coverage
Annual Reports
Earnings Releases
SEC Filings
Resources
Press Releases
Events & Presentations
IR Contact
E-mail Alerts
Corporate Governance
Governance Overview
Management Team
Board of Directors
Committee Composition
Contact the Board
FAQs
Form 8937
News
Careers
Unsubscribe
Financial Information
Financials Overview
Stock Information
Analyst Coverage
Annual Reports
Earnings Releases
SEC Filings
Resources
Press Releases
Events & Presentations
IR Contact
E-mail Alerts
Corporate Governance
Governance Overview
Management Team
Board of Directors
Committee Composition
Contact the Board
FAQs
Form 8937
Unsubscribe from all EyePoint Pharmaceuticals email alerts
Email Address
Leave this field blank
Print Page
Email Alerts
RSS News Feeds